See more : Bayer CropScience Limited (BAYERCROP.NS) Income Statement Analysis – Financial Results
Complete financial analysis of MRT Inc. (6034.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MRT Inc., a leading company in the Healthcare industry within the Healthcare sector.
- IGM Financial Inc. (IGIFF) Income Statement Analysis – Financial Results
- Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) Income Statement Analysis – Financial Results
- Resbud SE (RES.WA) Income Statement Analysis – Financial Results
- Ruentex Industries Ltd. (2915.TW) Income Statement Analysis – Financial Results
- RiverNorth Capital and Income Fund, Inc. (RSF) Income Statement Analysis – Financial Results
MRT Inc. (6034.T)
About MRT Inc.
MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling, and online medical care; Pocket Doctor, a telemedicine/health consultation app; groupware for medical offices; FASTCALL that consolidates the functions required for hospital crisis management system as safety confirmation service for medical institution; and Good Doctors, which provides owned media sent by doctors. It also offers nurse and pharmacist recruitment service; human resources introduction service for clinical laboratory engineers, radiologists, and dialysis nurses, as well as for new business openings and succession projects; and recruitment information service for exclusive industrial physicians and contract industrial physicians. In addition, the company engages in employment agency business, opening of business, business succession support business, and PR business, and career support business. Further, it offers services for supporting the operation of medical institutions, such as fund management, utilizing medical fee factoring, payroll calculation for doctors' part-time jobs, and payroll transfer agency services. Additionally, the company sells human umbilical cord-derived stem cell culture supernatant; and provides babysitter services, tax accountant referral service, credit card payment agency service, questionnaire survey request for pharmaceuticals, etc., as well as media coverage cooperation, lecture request, event rescue, etc. It also publishes books on illness and treatment; and offers health maintenance service and member comprehensive compensation systems. The company was formerly known as Medical Research and Technology Co., Ltd and changed its name to MRT Inc. in September 2014. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 5.41B | 8.74B | 4.47B | 2.56B | 2.63B |
Cost of Revenue | 2.14B | 3.14B | 916.20M | 805.08M | 982.90M |
Gross Profit | 3.27B | 5.60B | 3.55B | 1.76B | 1.65B |
Gross Profit Ratio | 60.49% | 64.04% | 79.50% | 68.58% | 62.64% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.50B | 2.62B | 2.13B | 1.49B | 0.00 |
Selling & Marketing | 801.00M | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 2.30B | 2.62B | 2.13B | 1.49B | 1.30B |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 2.30B | 2.62B | 2.29B | 1.49B | 1.30B |
Cost & Expenses | 4.44B | 5.76B | 3.20B | 2.30B | 2.28B |
Interest Income | 0.00 | 1.27M | 831.00K | 1.52M | 9.33K |
Interest Expense | 0.00 | 42.27M | 12.92M | 26.28M | 17.07M |
Depreciation & Amortization | 228.35M | 184.88M | 179.82M | 154.30M | 143.77M |
EBITDA | 1.10B | 3.13B | 1.45B | 407.58M | 410.09M |
EBITDA Ratio | 20.40% | 36.20% | 32.40% | 16.40% | 18.83% |
Operating Income | 967.00M | 2.98B | 1.27B | 264.36M | 351.69M |
Operating Income Ratio | 17.88% | 34.07% | 28.35% | 10.32% | 13.37% |
Total Other Income/Expenses | -99.27M | -41.00M | -12.09M | -24.76M | -102.43M |
Income Before Tax | 867.73M | 2.94B | 1.26B | 239.60M | 249.26M |
Income Before Tax Ratio | 16.05% | 33.60% | 28.08% | 9.35% | 9.47% |
Income Tax Expense | 319.35M | 754.04M | 451.07M | 80.66M | 91.42M |
Net Income | 517.00M | 2.16B | 774.49M | 131.81M | 144.80M |
Net Income Ratio | 9.56% | 24.72% | 17.33% | 5.14% | 5.50% |
EPS | 94.43 | 387.53 | 139.30 | 23.74 | 25.66 |
EPS Diluted | 94.37 | 387.21 | 138.79 | 23.62 | 25.55 |
Weighted Avg Shares Out | 5.48M | 5.57M | 5.56M | 5.55M | 5.64M |
Weighted Avg Shares Out (Dil) | 5.48M | 5.58M | 5.58M | 5.58M | 5.67M |
Source: https://incomestatements.info
Category: Stock Reports